Ligand validation:5XDQ

PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE

PEK is a Ligand Of Interest in 5XDQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XDQ_PEK_C_303	71%	57%	0.147	0.97	0.87	0.8	2	2	2	0	100%	1
5XDQ_PEK_P_303	70%	54%	0.147	0.966	0.9	0.89	2	2	2	0	100%	1
5XDQ_PEK_G_103	10%	51%	0.245	0.745	0.91	0.97	2	4	1	0	100%	1
5XDQ_PEK_T_102	8%	53%	0.229	0.702	0.96	0.88	2	3	3	0	100%	1
5XDQ_PEK_T_101	6%	51%	0.265	0.706	0.95	0.96	2	3	3	0	100%	1
5XDQ_PEK_C_304	3%	50%	0.238	0.574	0.94	0.98	2	2	3	0	100%	1
5B1A_PEK_G_101	93%	28%	0.08	0.973	1.2	1.66	5	12	6	0	100%	1
7COH_PEK_P_264	91%	54%	0.089	0.975	0.73	1.03	2	4	1	0	100%	1
7YPY_PEK_C_307	85%	53%	0.095	0.963	0.76	1.05	1	3	1	0	98%	0.9811
7VVR_PEK_P_303	82%	52%	0.106	0.961	0.69	1.14	2	5	3	0	100%	1
7VUW_PEK_C_303	82%	50%	0.109	0.964	0.67	1.23	1	5	1	0	100%	1
5B3S_PEK_C_302	81%	47%	0.118	0.97	0.85	1.18	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.